Design of Bifunctional Dendritic 5‑Aminolevulinic Acid and Hydroxypyridinone Conjugates for Photodynamic Therapy

Iron chelators have recently attracted interest in the field of photo­dynamic therapy (PDT) owing to their role in enhancement of intra­cellular proto­porphyrin IX (PpIX) generation induced by 5-amino­levulinic acid (ALA) via the biosynthetic heme cycle. Although ALA is widely used in PDT, cellular...

Full description

Saved in:
Bibliographic Details
Published inBioconjugate chemistry Vol. 29; no. 10; pp. 3411 - 3428
Main Authors Zhou, Tao, Battah, Sinan, Mazzacuva, Francesca, Hider, Robert C, Dobbin, Paul, MacRobert, Alexander J
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 17.10.2018
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Iron chelators have recently attracted interest in the field of photo­dynamic therapy (PDT) owing to their role in enhancement of intra­cellular proto­porphyrin IX (PpIX) generation induced by 5-amino­levulinic acid (ALA) via the biosynthetic heme cycle. Although ALA is widely used in PDT, cellular uptake of ALA is limited by its hydro­philicity. In order to improve ALA delivery and enhance the PpIX production, several dendrimers incorporating both ALA and 3-hydroxy-4-pyridinone (HPO) were synthesized. The ability of the dendrimers to enter cells and be metabolized to the PpIX photosensitizer was studied in several human cancer cell lines. The dendrimers were found to be significantly more efficient than ALA alone in PpIX production. The higher intra­cellular PpIX levels showed a clear correlation with enhanced cellular photo­toxicity following light exposure. Dendritic derivatives are therefore capable of efficiently delivering both ALA and HPO, which act synergistically to amplify in vitro PpIX levels and enhance PDT efficacy.
Bibliography:UKRI
ISSN:1043-1802
1520-4812
DOI:10.1021/acs.bioconjchem.8b00574